SUMITRA PATEL: Open Payments
NPI 1003497876 · PULASKI, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 68 payments from 12 companies in 2025. Trend: 2023 $1,003 · 2024 $1,265 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $204 |
| Janssen Pharmaceuticals, Inc | 12 | $185 |
| Alkermes, Inc. | 9 | $163 |
| Teva Pharmaceuticals USA, Inc. | 6 | $117 |
| Otsuka America Pharmaceutical, Inc. | 7 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $97 |
| ABBVIE INC. | 5 | $83 |
| Neurocrine BioSciences, Inc. | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
Products named: COBENFY, INVEGA SUSTENNA, ARISTADA, UZEDY, CAPLYTA, VRAYLAR, REXULTI, INGREZZA.
Industry payments across TN — which companies pay providers there.
